Ass.-Prof. Priv.-Doz. Mag. Dr. Stefan WÖHRL

1.        Meinke A, Barahmand-Pour F, Wöhrl S, Stoiber D, Decker T. Activation of different Stat5 isoforms contributes to cell-type-restricted signalling in response to interferons. Molecular and Cellular Biology. 1996: 16: 6937-6944.

2.        Wöhrl S, Kriechbaumer N, Hemmer W, Focke M, Brannath W, Götz M, Jarisch R. A cream containing DTPA (diethyltriaminepentaacetic acid) can protect from metal allergies. Contact Dermatitis. 2001 44: 224-228.

3.        Wöhrl S, Hemmer W, Focke M, Götz M, Jarisch R. Oral symptoms due to zinc as a minor component of dental amalgam. Contact Dermatitis. 2001 44: 252-253. (Case Report)

4.        Jarisch R, Wöhrl S, Focke M, Hemmer W. Anaphylaktische Reaktion bei spezifischer Immuntherapie durch Diaminoxidasehemmung nach Acetylcystein-Therapie. Allergologie. 2001 24: 112-115. (Case Report)

5.        Hemmer W, Wöhrl S, Focke M, Götz M, Jarisch R. Kontaktallergie auf "Superkleber" (Ethyl-2-cyanoacrylat) durch künstliche Fingernägel. Dermatol Beruf Umwelt. 2001 49: 115-118. (Case Report)

6.        Pötz H, Hemmer W, Wöhrl S, Jarisch R. Beta-Blocker, ACE-Hemmer und spezifische Immuntherapie. Allergo-Journal. 2001 10: 128. (Letter).

7.        Wöhrl S, Hemmer W, Focke M, Götz M, Jarisch R. The significance of fragrance-mix, balsam of Peru, colophony and propolis as screening tools in the detection of fragrance allergy. British Journal of Dermatology. 2001 145:268-273.

8.        Wöhrl S, Hemmer W. Placebos and pain management. Lancet. 2001 358: 1100-1101. (Letter)

9.        Wöhrl S, Hemmer W, Focke M, Götz M, Jarisch R. Copper allergy revisited. Journal of the American Academy of Dermatology. 2001 45: 863-870.

10.    Wöhrl S, Hemmer W, Focke M, Götz M, Jarisch R. Hypopigmentation after non-permanent henna tattoo. Journal of the European Academy of Dermatology and Venereology. 2001 15: 470-472. (Case Report)

11.    Hemmer W, Focke M, Kolarich D, Wilson IB, Altmann F, Wöhrl S, Götz M, Jarisch R. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. Journal of Allergy and Clinical Immunology. 2001 108: 1045-1052.

12.    Wöhrl S, Geusau A, Karlhofer F, Derfler K, Stingl G, Zillikens D. Pemphigoid gestationis: Treatment with Immunoapheresis. Journal of the German Society of Dermatology. 2003 1: 126-130. (Case Report)

13.    Wöhrl S, Hemmer W, Focke M, Götz M, Jarisch R. Patch testing in children, adults, and the elderly: Influence of age and sex on sensitization patterns. Pediatric Dermatology. 2003 20: 119-123.

14.       Focke M, Hemmer W, Wöhrl S, Götz M, Jarisch R, Kofler H. Specific sensitization to the Common house fly (Musca domestica) not related to insect panallergy. Allergy 2003 58: 448-451. (Case Report)

15.    Hemmer W, Focke M, Wöhrl S, Altmann F, Jarisch R. Die reziproke RAST-Inhibition bei Doppelpositivität auf Bienen- und Wespengift: Verbesserung durch Einschluss fucosylierter Glykoproteine? Allergo-Journal 2003:12(Suppl.1):48-50.

16.    Kofler H, Focke M, Hemmer W, Wöhrl S, Götz M, Jarisch R. Inhalationsallergie auf die Stubenfliege (Musca domestica). Allergo- Journal 2003: 12(Suppl.1): 43-44. (Case Report)

17.       Focke M, Hemmer W, Wöhrl S, Götz M, Jarisch R. Cross-reactivity between Ficus benjamina latex and fig fruit in patients with clinical fig allergy. Clinical and Experimental Allergy 2003 33: 971-977.

18.    Wöhrl S, Hayek B, Stingl G, Kinaciyan T. Late onset of type-1 allergic conjunctivitis in an elderly woman. Allergy 2003 58: 1197. (Case Report)

19.    Wöhrl S, Stingl G. Underestimation of allergies in elderly patients. Lancet. 2004 363: 259. (Letter)

20.    Wöhrl S, Focke M, Hinterhuber G, Stingl G, Binder M. Near-fatal anaphylaxis to Patent Blue V. British Journal of Dermatology: 2004 150:1037-1038. (Case Report)

21.    Wöhrl S, Hemmer W, Focke M, Rappersberger K, Jarisch R. Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine. Allergy and Asthma Proceeding. 2004 25(5): 305-311.

22.    Wöhrl S, Loewe R, Pickl WF, Stingl G, Wagner SN. EMPACT syndrome. Journal of the German Society of Dermatology. 2005 3: 39-43. (Case Report)

23.    Wöhrl S, Wagner SN. Response to Maja Mockenhaupt's and Jean-Claude Roujeau's letter to the editor. Journal of the German Society of Dermatology. 2005:3,570. (Letter)

24.    Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, Carlsen K-H, Cauwenberge P, Darsow U, Fokkens WJ, Haahtela T, Hoecke H, Jessberger B, Kowalski ML, Kopp T, Lahoz CN, Lodrup Carlsen KC, Papadopoulos NG, Ring J, Schmid-Grendelmeier P, Vignola AM, Wöhrl S, Zuberbier T. Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GA²LEN network. Allergy 2005 60:1287-1300.

25.    Prinz M, Vigl K, Wöhrl S. Automatic measurement of skin wheals provoked by skin prick tests.
Stud Health Technol Inform. 2005 116: 441-446.

26.    Wöhrl S, Vigl K, Binder M, Stingl G, Prinz M. Automated calculation of wheal size of skin prick tests. Experimental Dermatology. 2006 15: 119-124.

27.    Wöhrl S, Vigl K, Zehetmayer S, Hiller R, Jarisch R, Prinz M, Stingl G, Kopp T. The performance of a component-based allergen-microarray in clinical practice. Allergy 2006 61:633-9.

28.    Wöhrl S, Geusau A. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL. Acta Dermatovenerologica 2006 86:335-9.

29.    Wöhrl S, Vigl K, Stingl G. Patients with drug reactions – Is it worth testing? Allergy 2006 61:928-34.

30.    Wöhrl S, Jandl T, Stingl G, Kinaciyan T. Mobile telephone as new source for nickel dermatitis. Contact Dermatitis 2007 56: 113. (Case Report).

31.    Wöhrl S. Clinical Work-Up of Adverse Drug Reactions. Expert Reviews of Dermatology. 2007 2:217-31. (Invited Review).

32.    Wöhrl S, Gamper S, Hemmer W, Heinze G, Stingl G, Kinaciyan T. Premedication with montelukast reduces local reactions of allergen immunotherapy. Int Arch All Immunol. 2007: 144(2):137-42.

33.    Wöhrl S, Geusau A. Clinical update: Syphilis in adults. Lancet 2007 369(9577):1912-4. (Invited Review).

34.    Niżankowska-Mogilnicka E, Bochenek G, Mastalerz L, Świerczyńska M, Picado C, Scadding G, Kowalski ML, Setkowicz M,  Ring J, Brockow K, Bachert C, Wöhrl S, Dahlén B, Szczeklik A. EAACI/GA²LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007 62(10):1111-8. (Review).

35.    Wöhrl S, Schnedl J, Auer H, Walochnik J, Stingl G, Geusau A. Successful treatment of a married couple for American leishmaniasis with miltefosine. J Europ Acad Dermatol Venereol. 2008 22(2):258-9. (Case Report)

36.    Shaheen S, Potts J, Gnatiuc L, Kowalski  ML, Joos G, van Zele T, van Durme Y, De Rudder I, Wöhrl S, Godnic-Cvar J, Skadhauge L, Thomsen G, Zuberbier T, Bergmann KC, Heinzerling L, Gjomarkaj M, Bruno A, Pace E, Bonini S, Fokkens W, Weersink EJ, Loureiro C, Villanueva CM, Sanjuas C, Zock JP, Janson C, Burney P. The relation between paracetamol use and asthma: a GA²LEN European case-control study. Eur Respir J. 2008 32(5):1231-6.

37.    Burney P, Potts J, Makowska J, Kowalski M, Phillips J, Gnatiuc L, Shaheen S, Joos G, Van Cauwenberge P, van Zele T, Verbruggen K, van Durme Y, Derudder I, Wöhrl S, Godnic-Cvar J, Salameh B, Skadhauge L, Thomsen G, Zuberbier T, Bergmann KC, Heinzerling L, Renz H, Al-Fakhri N, Kosche B, Hildenberg A, Papadopoulos NG, Xepapadaki P, Zannikos K, Gjomarkaj M, Bruno A, Pace E, Bonini S, Bresciani M, Gramiccioni C, Fokkens W, Weersink EJ, Carlsen KH, Bakkeheim E, Loureiro C, Villanueva CM, Sanjuas C, Zock JP, Lundback B, Janson C. A case-control study of the relation between plasma selenium and asthma in European populations: a GA²LEN project. Allergy. 2008 63(7):865-71.

38.    Wöhrl S. The potential of allergen biochips. Recent Pat Inflamm Allergy Drug Discov 2008 2:186-90. (Review)

39.    Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin Exp Dermatol. 2009; 34(3):355-7.

40.    Jalili A, Kinaciyan T, Barisani T, Peck-Radosavljevic M, Stingl G, Geusau A, Wöhrl S. Successful Treatment of Refractory Behçet's Disease with the TNF-alpha Blocker Infliximab. Iran J Immunol. 2009 6(1):55-8. (Case Report)

41.    Heinzerling LM, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet PJ, Bresciani M, Bruno A, Burney P, Canonica GW, Darsow U, Demoly P, Durham S, Fokkens WJ, Giavi S, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski ML, Magyar P, Muraközi G, Orosz M, Papadopoulos NG, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Zuberbier T. GA²LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy. 2009 64(10):1498-506.

42.    Burbach GJ, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet PJ, Bresciani M, Bruno A, Canonica GW, Darsow U, Demoly P, Durham S, Fokkens WJ, Giavi S, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski ML, Magyar P, Muraközi G, Orosz M, Papadopoulos NG, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Zuberbier T. GA²LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009 64(10):1507-15.

43.    Wöhrl S, Radon K, Ring J, Moritz K, Akdis C, Burney P, Van Cauwenberge P, Bousquet J, Zuberbier T. GA²LEN (Global Allergy and Asthma European Network), die Perspektive der deutschsprachigen Zentren. Wien Klin Wochenschr. 2009 121(17-18):589-97. (Review)

44.    Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML, Magyar P, Muraközi G, Orosz M, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Bousquet J, Zuberbier T. GA²LEN skin test study III: minimum battery of test inhalant allergens needed in epidemiological studies in patients. Allergy. 2009 64(11):1656-62.

45.    Meyer N, Zimmermann M, Bürgler S, Bassin C, Woehrl S, Moritz K, Rhyner C, Indermitte P, Schmid-Grendelmeier P, Akdis M, Menz G, Akdis CA. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol. 2010 125(4):858-65 e10.

46.    Seidel S, Voller B, Geusau A, Wöhrl S. Severe anaphylaxis to hymenoptera stings – Does the basal serum tryptase really matter? Annals of Allergy Asthma and Immunology. 2010 105(2):185-7. (Case Report)

47.    Zimmermann M, Koreck A, Meyer N, Basinski T, Meiler F, Simone B, Woehrl S, Moritz K, Eiwegger T, Schmid-Grendelmeier P, Kemeny L, Akdis CA. TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol. 2011 127(1):200-207.e10.

48.    Handisurya A, Moritz KB, Riedl E, Reinisch C, Stingl G, Wöhrl S. Fixes Arzneimittelexanthem auf Mefenaminsäure: Eine Fallserie und diagnostische Algorithmen. J Dtsch Dermatol Ges. 2011 May;9(5):374-8.